Moreover, the loss of FBXW7 has been extensively studied and consistently linked to the pathogenesis of cancer, as well as tumor metastasis, poor clinical outcomes, and resistance to a range of cancer treatments including chemotherapy, radiation therapy, and immunotherapy (45, 46). This evidence concerns the gene FBXW7 and cancer.